Golden State Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Golden State Newswire.

Press releases published on September 9, 2026

Sep. 9, 2026

AEON Announces Positive Pilot Forced Degradation Results Supporting Analytical Comparability of ABP-450 to BOTOX®

Indeterminate GlobeNewswire

Sep. 9, 2026

EVgo and Regency Expand National Partnership to Bring Fast Charging to More Retail Centers Across the U.S. 

Indeterminate GlobeNewswire

Sep. 9, 2026

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire

Sep. 9, 2026

NeOnc Technologies Holdings, Inc. Announces Pricing of $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules with New and Existing Institutional Investors

Indeterminate GlobeNewswire

Sep. 9, 2026

Highwire Launches AcroAnswers, Giving Brands Direct Access to Measure and Improve Their AI Visibility

Indeterminate GlobeNewswire

Sep. 9, 2026

ISB Global Services Introduces Truepic’s Authenticated Visual Evidence to Accelerate Canadian Insurer Workflows

Indeterminate GlobeNewswire

Sep. 9, 2026

HP Extends Data-Center AI Architecture to the Edge

Indeterminate GlobeNewswire

Sep. 9, 2026

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

American Gold & Copper Inc. (OTC: AGCI) Signs Definitive $10 Million Acquisition Agreement for 1,540-Acre Rimrock Copper-Gold Project in Nevada

Indeterminate GlobeNewswire

Sep. 9, 2026

Directive Launches Expanded Communications Division, Bringing Performance Principles to B2B PR, Social and Influencer Marketing

Indeterminate GlobeNewswire

Sep. 9, 2026

Accumulus Technologies Announces Acquisition by Eir Partners to Accelerate Next Phase of Growth

Indeterminate GlobeNewswire

Sep. 9, 2026

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Indeterminate GlobeNewswire

Sep. 9, 2026

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

Indeterminate GlobeNewswire

Sep. 9, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Rezolute Provides Update on FDA Review of its Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism

Indeterminate GlobeNewswire

Sep. 9, 2026

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire

Sep. 9, 2026

MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management

Indeterminate GlobeNewswire

Sep. 9, 2026

RadNet to Host Free Prostate Cancer Webinar on September 19, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

Indeterminate GlobeNewswire

Sep. 9, 2026

EAIGG and Draup Launch “The AI Sovereignty Paradox,” Introducing a New Framework for Understanding National AI Competitiveness

Indeterminate GlobeNewswire